A multicentre, retrospective, real-world study of Ruxolitinib treatment for polycythemia vera
Latest Information Update: 14 Sep 2021
At a glance
- Drugs Ruxolitinib (Primary)
- Indications Polycythaemia vera
- Focus Adverse reactions; Therapeutic Use
- 14 Sep 2021 New trial record